Phospho-PDGFR α/β (Tyr849/Tyr857) Antibody (Rabbit mAb) [B8C12]

CatNo: F2630

    Application: Reactivity:
    • Lane 1: 3T3, Lane 2: 3T3 (hPDGF-BB, 50ng/ml, 10 min)
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    SDS-PAGE の分離ゲルの推奨濃度:5%

    使用情報

    Dilution
    1:1000
    1:50
    Application
    WB, IP
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human, Mouse, Rat
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    123 kDa
    ポジティブコントロール NIH/3T3 cells (PDGFbb treated)
    ネガティブコントロール

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution ( recommending 5% BSA solution) for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

    Datasheet & SDS

    生物学的記述

    Specificity
    Phospho-PDGFR α/β (Tyr849/Tyr857) Antibody (Rabbit mAb) [B8C12] detects endogenous levels of PDGFR α and β only when phosphorylated on Tyr849 of PDGFRα and Tyr857 of PDGFRβ.
    タンパク質の局在
    細胞膜、細胞突起、ゴルジ装置、細胞内膜系、細胞質小胞、リソソーム
    Uniprot ID
    P16234, P09619
    Clone
    B8C12
    Synonym(s)
    Activated tyrosine kinase PDGFRB; CD140; CD140A; CD140a antigen; CD140B; IBGC4; IMF1; JTK12; KOGS; PDGF-R-alpha; PDGF-R-beta; PDGFR; PDGFR alpha; PDGFR beta; PDGFR-1; PDGFR-2; PDGFR-alpha; PDGFR-beta; PDGFR1; PDGFR2; PDGFRA; PDGFRalpha
    Background
    Phosphorylated PDGF receptor α at Tyr849 and PDGF receptor β at Tyr857 represent activation loop phosphotyrosine states of closely related class III receptor tyrosine kinases that define their catalytically active conformation and initiate a network of downstream signaling cascades in response to binding of disulfide‑linked PDGF dimers, including PDGF‑AA, AB, BB, CC and DD, with isoform‑ and dimer‑specific patterns of receptor homodimer and α/β heterodimer engagement. The receptors share a common structural organization composed of an extracellular ligand‑binding region with five immunoglobulin‑like domains, a single transmembrane segment and a cytoplasmic portion containing a split tyrosine kinase domain with an activation loop and a kinase insert, flanked by regulatory sequences in the juxtamembrane and C‑terminal tail; ligand binding drives receptor dimerization and trans‑autophosphorylation, and structural/functional analyses identify Tyr849 in PDGFRα and Tyr857 in PDGFRβ within the activation loop as key autophosphorylation sites whose modification stabilizes the active kinase conformation and is necessary for efficient phosphorylation of additional regulatory tyrosines that serve as docking sites for SH2‑domain signaling effectors. Once Tyr849/Tyr857 are phosphorylated, PDGFRα/β recruit a spectrum of SH2‑containing proteins, including GRB2–SOS to activate RAS–RAF–MEK–ERK, PI3K (via p85 binding to Tyr751 and neighboring sites in PDGFRβ) to stimulate AKT and mTOR signaling, PLCγ to drive DAG/IP₃‑mediated calcium mobilization and PKC activation, SRC family kinases, SHP2 phosphatase and STAT transcription factors, collectively controlling mitogenesis, survival, actin cytoskeleton remodeling, chemotaxis, angiogenesis and differentiation of mesenchymal lineages such as fibroblasts, vascular smooth muscle cells, pericytes and oligodendrocyte precursors. PDGFRα homodimers preferentially bind PDGF‑AA, AB, BB and CC, PDGFRβ homodimers bind PDGF‑BB and PDGF‑DD as well as PDGF‑AB, and α/β heterodimers respond to PDGF‑B, C and D and PDGF‑AB, and these distinct receptor/ligand combinations, together with cell‑type‑specific expression of PDGFRα versus PDGFRβ, define the balance between proliferative and chemotactic responses; PDGFRβ homodimers and α/β heterodimers are strong stimulators of chemotaxis in fibroblasts and smooth muscle cells, whereas PDGFRα homodimers can inhibit chemotaxis and bias signaling toward proliferation, with Tyr849/Tyr857 phosphorylation acting as the primary switch between inactive and signaling‑competent states in each dimer context. PDGF signaling and PDGFRα/β activation loop phosphorylation are central to organ development, including glomerular capillary tuft formation, lung and intestinal epithelial folding and neural crest–derived connective tissue patterning, and aberrations in the PDGF/PDGFR pathway, such as gain‑of‑function receptor mutations or overexpression, lead to uncontrolled mesenchymal proliferation and enhanced angiogenesis characteristic of malignancies, vascular proliferative disorders and fibrotic diseases. Phospho‑specific antibodies recognizing PDGFRα Tyr849 and PDGFRβ Tyr857 are widely used to quantify receptor activation state and PDGF pathway engagement in biochemical assays and tumor samples, and Tyr849/Tyr857 phosphorylation serves as a mechanistic readout in studies of PDGFR inhibitors and modulators of receptor function, which target this activation loop–dependent catalytic activity to block PDGF‑driven growth, migration and neovascularization.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください